Degnan Chris

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 35% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Degnan Chris's trades of Urogen Pharma Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
488.23
Quantity 90,234 -0.3%
Value US$1,946,469
Transaction date
Proposed sale
Price
112.06
Quantity 58,849
Value US$1,391,031
Transaction date
Sale
Price
434.23
Quantity 91,353 -30.4%
Value US$2,012,244
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-09 2026-10-08
S Sale
90,234 -0.3%
488.23
US$1,946,469 		90,234 -0.3% 488.23 US$1,946,469
2026-10-09 2026-10-08
PrS Proposed sale
58,849
112.06
US$1,391,031 		58,849 112.06 US$1,391,031
2025-10-09 2025-10-08
S Sale
91,353 -30.4%
434.23
US$2,012,244 		91,353 -30.4% 434.23 US$2,012,244
2023-03-14 2023-03-13
B Purchase
10,000 +inf%
1.96
US$19,593 		10,000 +inf% 1.96 US$19,593